Beacon Clinical Research

Beacon Clinical Research

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

Beacon Clinical Research is a private, service-based contract research organization (CRO) that has been operational since 2005. It generates revenue by providing clinical trial execution services to pharmaceutical and biotechnology sponsors, leveraging its location in a major biotech hub and a track record of hundreds of completed trials. The company operates a single clinical site, focusing on patient recruitment and trial management rather than developing its own therapeutic assets. Its business model is built on offering sponsors access to a skilled investigator team and a compliant, convenient facility for conducting clinical research.

DepressionChronic PainFibromyalgiaOveractive BladderAcneDiabetesOsteoarthritis

Technology Platform

Operational clinical trial execution platform consisting of a state-of-the-art clinical facility, GCP/IAA-compliant processes, experienced physician investigators, and patient recruitment systems. No proprietary drug discovery or digital health technology.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

The company is positioned in the major biotech hub of Boston, providing direct access to a high concentration of potential sponsor clients and a large patient population.
The growing global clinical trials outsourcing market and sustained biopharma R&D investment create a favorable demand environment for reliable clinical research sites.

Risk Factors

Revenue is entirely dependent on winning competitive contracts from sponsor companies, and profitability is tied to successful patient recruitment.
As a single-site operation, it faces scalability limits and geographic concentration risk, alongside constant regulatory compliance exposure that could threaten its operating status.

Competitive Landscape

Beacon competes with other independent clinical research sites, site management organizations (SMOs), and the site networks of large global CROs in the Boston area. Its differentiation is based on its long local tenure, therapeutic area experience, and positioning as a leading independent center, rather than on scale or technology.